Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Vaccinia Related Kinase 2 (VRK2) Peptid

VRK2 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5511626

Kurzübersicht für Vaccinia Related Kinase 2 (VRK2) Peptid (ABIN5511626)

Target

VRK2 (Vaccinia Related Kinase 2 (VRK2))

Spezies

Human

Quelle

  • 3
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-VRK2 antibody (Catalog #: ARP74346_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    VRK2 (Vaccinia Related Kinase 2 (VRK2))

    Hintergrund

    This gene encodes a member of the vaccinia-related kinase (VRK) family of serine/threonine protein kinases. The encoded protein acts as an effector of signaling pathways that regulate apoptosis and tumor cell growth. Variants in this gene have been associated with schizophrenia. Alternative splicing results in multiple transcript variants that differ in their subcellular localization and biological activity.

    Protein Size: 397

    Molekulargewicht

    43 kDa

    Gen-ID

    7444
Sie sind hier:
Chat with us!